Columbus, Ohio
Colorectal cancer clinical trials in Columbus, OH
35 colorectal cancer studies are recruiting participants at sites in Columbus as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Columbus at a glance
- 35 studies are recruiting at a site in Columbus.
- By phase: Phase 1 (6), Phase 1/2 (8), Phase 2 (4), Phase 2/3 (2), Phase 3 (4), Phase 4 (1), No phase (6), Observational (4). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (22), university, hospital or other (11), government (2).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Columbus
Basic details from each study's public record (the 30 most recently updated of 35). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT05863195 · updated
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT06102902 · updated
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- No phase
- Ages 45 to 70
- All sexes
- Sponsor
- NRG Oncology
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT05080673 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Mount Carmel East Hospital · Mount Carmel Health Center West · Ohio State University Comprehensive Cancer Center
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Mount Carmel East Hospital · Mount Carmel Health Center West · Ohio State University Comprehensive Cancer Center
- Registry record
- NCT05334069 · updated
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- The Ohio State University (OSU) Wexner Medical Center
- Registry record
- NCT06400472 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- The Jame Outpatient Care West Campus
- Registry record
- NCT07397338 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT05673148 · updated
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- Ohio State University
- Registry record
- NCT03526835 · updated
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- Ohio State University-Arthur G James Comprehensive Cancer Center
- Registry record
- NCT07284849 · updated
Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- Ohio State University
- Registry record
- NCT06710756 · updated
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- A2 Biotherapeutics Inc.
- Study site
- The Ohio State University Comprehensive Cancer Center
- Registry record
- NCT04981119 · updated
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center
- Registry record
- NCT07221357 · updated
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT05630794 · updated
SMP-3124LP in Adults With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Sumitomo Pharma America, Inc.
- Study site
- Ohio State University
- Registry record
- NCT06526819 · updated
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kura Oncology, Inc.
- Study site
- Ohio State University
- Registry record
- NCT06026410 · updated
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT06424522 · updated
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ALX Oncology Inc.
- Study site
- ALX Center 10
- Registry record
- NCT07085091 · updated
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Phase 2
- Ages 18 to 130
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT05489211 · updated
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Medtronic - MITG
- Study site
- The Ohio State University Wexner Medical Center
- Registry record
- NCT07351071 · updated
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Marengo Therapeutics, Inc.
- Study site
- The Ohio State University Comprehensive Cancer Center
- Registry record
- NCT05592626 · updated
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Xencor, Inc.
- Study site
- Xencor Investigative Site
- Registry record
- NCT05433142 · updated
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Study site
- The Ohio State University Comprehensive Cancer Center
- Registry record
- NCT06948448 · updated
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Canadian Cancer Trials Group
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT06205485 · updated
Strategies for Optimizing a Mailed FIT Program in Appalachia
- No phase
- Ages 45 to 74
- All sexes
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT07173985 · updated
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
- Phase 4
- Ages 18 and older
- All sexes
- Sponsor
- Takeda
- Study site
- Zangmeister Cancer Center
- Registry record
- NCT06562543 · updated
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Rapamycin Holdings Inc.
- Study site
- Ohio State University
- Registry record
- NCT06950385 · updated
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Turning Point Therapeutics, Inc.
- Study site
- The Ohio State University Wexner Medical Center
- Registry record
- NCT03093116 · updated
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
- Phase 2
- Ages 50 and older
- Female participants
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT07407647 · updated
Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT06746012 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Columbus, OH on ClinicalTrials.gov.
Ask about studies near Columbus
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Ohio
All Ohio locations
91 studies recruiting across 54 cities.
Cleveland
36 studies recruiting.
Cincinnati
30 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections